On 19 July 2021, the Government accepted the final advice of the independent Joint Committee on Vaccination and Immunisation (JCVI) to offer vaccination to children and young people aged 12 years old and over with specific underlying health conditions that put them at risk of serious outcomes from COVID-19.<\/p>
The National Health Service are asking local systems to have plans in place to invite eligible children for a first dose as soon as possible, with the second dose offered eight weeks later. Operational guidance will be issued to the service, including paediatricians. We are ensuring a robust process is in place for the identification and invitation of all eligible children and young people. Public Health England are currently updating the Green Book for public health professionals, including paediatricians, to reflect the updated at-risk groups who should receive vaccination.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-07-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-07-27T15:41:30.623Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-07-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Children"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what role paediatricians will have in identifying children eligible for the covid-19 vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"} } , "tablingMemberConstituency" : {"_value" : "York Central"} , "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"} ], "uin" : "36670"} , {"_about" : "http://data.parliament.uk/resources/1348721", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1348721/answer", "answerText" : {"_value" : "
While Public Health England (PHE) plans to publish national data on hospitalisation by vaccination status in due course, there are currently no plans to publish local infection rates by vaccination status.<\/p>
The technical briefing published by PHE provides the latest data regarding hospitalisations and deaths by variant, including the Delta variant, as well as data concerning those hospitalised with the Delta variant who are vaccinated with one and both doses and those unvaccinated. This data is available at the following link:<\/p>
https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-07-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-07-27T15:44:26.387Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-07-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will publish information on local infection rates and hospitalisations according to vaccination status.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "36672"}
, {"_about" : "http://data.parliament.uk/resources/1347476", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1347476/answer", "answerText" : {"_value" : " The Government has accepted the Joint Committee on Vaccination and Immunisation (JCVI) advice that young people, including students, may be offered a COVID-19 vaccination within three months of turning 18 years old. The second dose of the vaccine would be offered eight weeks after the first dose.<\/p> Students over the age of 16 years old with underlying health conditions that put them at risk of serious outcomes from COVID-19 have been offered both doses of vaccine as part of phase one of the vaccine deployment programme. Age is assessed to be the strongest factor linked to mortality, morbidity and hospitalisations.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-07-20", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "33895"}
, {"_value" : "33972"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-07-20T15:26:36.627Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-07-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure that young people who (a) will turn 18 in July or August and (b) are going to university in 2021 have been offered both doses of a covid-19 vaccination prior to the commencement of the university new term.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "33971"}
, {"_about" : "http://data.parliament.uk/resources/1347478", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1347478/answer", "answerText" : {"_value" : " The Government has accepted the Joint Committee on Vaccination and Immunisation (JCVI) advice that young people, including students, may be offered a COVID-19 vaccination within three months of turning 18 years old. The second dose of the vaccine would be offered eight weeks after the first dose.<\/p> Students over the age of 16 years old with underlying health conditions that put them at risk of serious outcomes from COVID-19 have been offered both doses of vaccine as part of phase one of the vaccine deployment programme. Age is assessed to be the strongest factor linked to mortality, morbidity and hospitalisations.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-07-20", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "33895"}
, {"_value" : "33971"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-07-20T15:26:36.737Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-07-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to young people who may be under the age of 18 when going to university in September 2021, if he will make an assessment of the potential merits of offering those young people covid-19 vaccines if they are over the age of 16.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "33972"}
, {"_about" : "http://data.parliament.uk/resources/1346757", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1346757/answer", "answerText" : {"_value" : " No specific assessment has been made. Information on the uptake of the COVID-19 vaccine following a supported conversation is not collected as part of the vaccine record.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-07-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-07-29T15:48:57.893Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-07-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the uptake of the covid-19 vaccine following a supported conversation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "33268"}
, {"_about" : "http://data.parliament.uk/resources/1346759", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1346759/answer", "answerText" : {"_value" : " There is evidence from a range of studies that COVID-19 vaccines are effective at preventing infection with the COVID-19 virus. Public Health England (PHE) participated in two studies, which looked at vaccine effectiveness against COVID-19 infection in different populations, including the impact of vaccination on infection, viral load and transmission.<\/p> The studies have been published in The Lancet at the following link:<\/p> <\/p> https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00354-6/fulltext<\/a><\/p> <\/p>
Outcome<\/p><\/td> | Vaccine Effectiveness<\/p><\/td><\/tr> | |||
Pfizer/BioNTech<\/p><\/td> | Oxford/AstraZeneca<\/p><\/td><\/tr> | |||
1 dose<\/p><\/td> | 2 doses<\/p><\/td> | 1 dose<\/p><\/td> | 2 doses<\/p><\/td><\/tr> | |
Symptomatic disease<\/p><\/td> | 55-70%*<\/p><\/td> | 85-95%*<\/p><\/td> | 55-70%*<\/p><\/td> | 70-85%**<\/p><\/td><\/tr> |
Hospitalisation<\/p><\/td> | 75-85%*<\/p><\/td> | 90-99%**<\/p><\/td> | 75-85%*<\/p><\/td> | 80-99%***<\/p><\/td><\/tr> |
Mortality<\/p><\/td> | 70-80%**<\/p><\/td> | 95-99%**<\/p><\/td> | 75-85%**<\/p><\/td> | 75-99%***<\/p><\/td><\/tr> |
Infection<\/p><\/td> | 55-70%**<\/p><\/td> | 70-90%***<\/p><\/td> | 60-70%***<\/p><\/td> | No data<\/p><\/td><\/tr> |
Transmission (secondary cases)^<\/p><\/td> | 45-50%***<\/p><\/td> | No data<\/p><\/td> | 35-50%***<\/p><\/td> | No data<\/p><\/td><\/tr><\/tbody><\/table> <\/p> |